• Home
  • EMCrit
  • PulmCrit
  • IBCC
  • 1:1
  • ODR
  • About
    • About EMCrit
    • PulmCrit – The Full Story
    • EMCrit FAQ
    • Subscribe to the Newsletter
  • Contact
  • Join
    • Why Should I Become a Member?
    • Questions Before Joining (FAQ)
    • Join Now!

Internet Book of Critical Care (IBCC)

Online Medical Education on Emergency Department (ED) Critical Care, Trauma, and Resuscitation

  • ToC
  • About the IBCC
  • Tweet Us
  • RSS
  • IBCC Podcast
You are here: Home / IBCC / Thoracic Radiology – Distribution of parenchymal abnormalities


Thoracic Radiology – Distribution of parenchymal abnormalities

October 1, 2023 by Josh Farkas

CONTENTS

  • Peripheral vs. central
    • Peripheral
      • Peripheral consolidation ➡️
    • Central
  • Peribronchovascular
  • Upper vs. lower
    • Upper lung predominant
    • Midlung predominant
    • Lower lung predominant
  • Migratory infiltrates
  • Distribution of bronchiectasis ➡️
  • Questions & discussion

abbreviations used in the pulmonary section:

  • AE-ILD: Acute exacerbation of ILD 📖
  • AIP: Acute interstitial pneumonia (Hamman-Rich syndrome) 📖
  • ANA: Antinuclear antibody 📖
  • ANCA: Antineutrophil cytoplasmic antibodies 📖
  • ARDS: Acute respiratory distress syndrome 📖
  • ASS: Antisynthetase Syndrome 📖
  • BAL: Bronchoalveolar lavage 📖
  • BiPAP: Bilevel positive airway pressure 📖
  • COP: Cryptogenic organizing pneumonia 📖
  • CPAP: Continuous positive airway pressure 📖
  • CPFE: Combined pulmonary fibrosis and emphysema 📖
  • CTD-ILD: Connective tissue disease associated interstitial lung disease 📖
  • CTEPH: Chronic thromboembolic pulmonary hypertension 📖
  • DAD: Diffuse alveolar damage 📖
  • DAH: Diffuse alveolar hemorrhage 📖
  • DIP: Desquamative interstitial pneumonia 📖
  • DLCO: Diffusing capacity for carbon monoxide 📖
  • FEV1: Forced expiratory volume in 1 second 📖
  • FVC: Forced vital capacity 📖
  • GGO: Ground glass opacity 📖
  • GLILD: Granulomatous and lymphocytic interstitial lung disease 📖
  • HFNC: High flow nasal cannula 📖
  • HP: Hypersensitivity pneumonitis 📖
  • IPAF: Interstitial pneumonia with autoimmune features 📖
  • IPF: Idiopathic pulmonary fibrosis 📖
  • IVIG: Intravenous immunoglobulin 📖
  • LAM: Lymphangioleiomyomatosis 📖
  • LIP: Lymphocytic interstitial pneumonia 📖
  • MCTD: Mixed connective tissue disease 📖
  • NIV: Noninvasive ventilation (including CPAP or BiPAP) 📖
  • NSIP: Nonspecific interstitial pneumonia 📖
  • NTM: Non-tuberculous mycobacteria 📖
  • OP: Organizing pneumonia 📖
  • PAP: Pulmonary alveolar proteinosis 📖
  • PE: Pulmonary embolism 📖
  • PFT: Pulmonary function test 📖
  • PLCH: Pulmonary Langerhans Cell Histiocytosis 📖
  • PPFE: Pleuroparenchymal fibroelastosis 📖
  • PPF: Progressive pulmonary fibrosis 📖
  • PVOD/PCH Pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis 📖
  • RB-ILD: Respiratory bronchiolitis-associated interstitial lung disease 📖
  • RP-ILD: Rapidly progressive interstitial lung disease 📖
  • TNF: tumor necrosis factor
  • UIP: Usual Interstitial Pneumonia 📖

peripheral

(back to contents)


disorders that may have a peripheral distribution

  • Most eosinophilic pneumonias:
    • CEP (chronic eosinophilic pneumonia).
    • EGPA (eosinophilic granulomatosis with polyangiitis)(consolidations tend to have a lobular distribution, often associated with centrilobular nodules). (29286851)
    • Simple pulmonary eosinophilia.
    • HES (hypereosinophilic syndrome).
  • OP (organizing pneumonia).
  • Sarcoidosis.
  • Drug-induced pneumonia (e.g., amiodarone).
  • Emboli:
    • Infarct due to PE (pulmonary embolism).
    • Septic pulmonary embolism.
    • Silicone embolism syndrome.
  • Diffuse ILDs (most interstitial lung diseases have a peripheral distribution):
    • IPF (idiopathic pulmonary fibrosis).
    • NSIP (nonspecific interstitial pneumonia is usually peripheral, but may also have peripheral sparing).
    • DIP (desquamative interstitial pneumonia).
    • Asbestosis.
  • Pulmonary contusion.
  • Lymphomatoid granulomatosis.
  • Adenocarcinoma.
  • IgG4-related lung disease.
  • COVID-19.

central

(back to contents)


radiographic appearance/definition

  • Chest X-ray:
    • Central distribution is most notable in the perihilar regions. This is often referred to as a “butterfly” or “batwing” distribution.
    • Lung apices, costophrenic angles, and periphery may be spared.
  • CT scan: Central distribution is most notable due to sparing of the lung periphery.

differential diagnosis

  • Certain forms of pulmonary edema:
    • Cardiogenic pulmonary edema.
    • Neurogenic pulmonary edema.
  • Inhalational lung injury, including:
    • EVALI (E-cigarette and vaping-associated lung injury).
    • Crack lung.
  • DAH (diffuse alveolar hemorrhage):
    • Tends to be more pronounced centrally.
    • Often spares the costophrenic angle, apices, and lung periphery.
  • Pneumocystis (may have sparing of the subpleural lung).
  • Interstitial lung diseases:
    • NSIP (nonspecific interstitial pneumonia may have subpleural sparing in ~20% of patients).
    • Organizing pneumonia. (34246383)
    • PLCH (pulmonary Langerhans cell histiocytosis often spares the costophrenic angles and tips of the middle lobes)
  • Malignancy:
    • Lymphoproliferative diseases.
    • Lymphangitic carcinomatosis.
    • Kaposi sarcoma.
    • Therapeutic injection of radioactive Yttrium-labeled microspheres (with embolization to the lungs).(24460448)
  • PAP (pulmonary alveolar proteinosis).
Idiopathic pulmonary hemosiderosis causing diffuse alveolar hemorrhage. The chest X-ray illustrates attributes of a central distribution: sparing of the apices, lung periphery, and costophrenic angles.(Courtesy of Ian Bickle, Radiopaedia)
Bilateral alveolar consolidation due to DAH from lupus.(22934226)

peribronchovascular distribution

(back to contents)


basics

  • Peribronchovascular distributions result from disease localized to the airways, vasculature, and/or lymphatics.
  • ⚠️ Micronodules that are distributed in a peribronchovascular fashion are discussed further here: 📖 The following discussion applies to larger nodules or consolidations arranged in a peribronchovascular distribution.

differential diagnosis of peribronchovascular disease

infection

  • Bronchopneumonia:
    • Often associated with tree-in-bud abnormalities.
    • Note that this can be caused by some viruses (e.g., HSV).
    • Further discussion of bronchopneumonia: 📖
  • Fungal:
    • Airway-invasive aspergillosis.

inflammatory

  • OP (organizing pneumonia).
  • CEP (chronic eosinophilic pneumonia).
  • Sarcoidosis.
  • Vasculitis:
    • GPA (granulomatosis with polyangiitis).
    • EGPA (eosinophilic granulomatosis with polyangiitis).

malignant and/or lymphoproliferative

  • Lymphomatoid granulomatosis.
  • KS (Kaposi sarcoma).
  • Primary pulmonary lymphoma.
  • FB/LIP (Follicular bronchiolitis & lymphocytic interstitial pneumonitis).
  • Pulmonary adenocarcinoma.
  • IgG4-related lung disease.
  • Pulmonary leukemic infiltrates.

other

  • Inhalational injury.
Kaposi Sarcoma: innumerable ill-defined flame-shaped nodules in a peribronchovascular distribution within the lower lungs.(29209425)

Additional information: Excellent review article by Ko et al. is available here: 📄 Table 1 and Figure 2 contain some useful algorithms.


upper vs. lower

(back to contents)


Lungs are thicker at the bases, which may tend to cause the bases to appear more diseased. A lateral film may help accurately determine if the upper lung is preferentially involved.


upper lung zone predominant
  • Infectious:
    • Reactivation tuberculosis.
    • Fungus (e.g., chronic histoplasmosis).
    • Pneumocystis in a patient who received aerosolized pentamidine.
  • Inflammatory:
    • Sarcoidosis (& Berylliosis).
    • Rheumatoid arthritis (necrobiotic nodular form; may cavitate and mimic infection).(36566029)
    • CEP (chronic eosinophilic pneumonia).
    • PPFE (pleuroparenchymal fibroelastosis).
    • Ankylosing spondylitis.
  • Exposure-related:
    • HP (hypersensitivity pneumonitis).
    • Respiratory bronchiolitis.
    • Pneumoconiosis, including:
      • Silicosis.
      • Coal workers pneumoconiosis.
  • “Apical cap” or “pleural cap.” (35680316) – Normal variant that is more common in older patients. Abnormalities are usually restricted to the apical 5 mm. Progression over time is rare.
  • Other:
    • PLCH (pulmonary Langerhans cell histiocytosis).
    • MPC (metastatic pulmonary calcification).

mid-lung predominant
  • Sarcoidosis.
  • Cardiogenic pulmonary edema.
  • Pneumocystis.

lower lung zone predominant
  • Interstitial pneumonias:
    • IPF (idiopathic pulmonary fibrosis).
    • Asbestosis.
    • NSIP (nonspecific interstitial pneumonia).
    • Connective tissue-related interstitial lung disease.
    • DIP (desquamative interstitial pneumonia).
    • LIP (lymphoid interstitial pneumonia).
  • Aspiration:
    • Aspiration pneumonia.
    • Aspiration bronchiolitis.
    • Lipoid pneumonia.
  • Hematogenous:
    • Hematogenous metastases.
    • Septic emboli.

migratory infiltrates

(back to contents)


Causes of infiltrates which appear to migrate over time include:

recurrent, discrete events:

  • Recurrent aspiration events.
  • Recurrent pneumonias in the context of immunosuppression.
  • Recurrent pulmonary emboli causing pulmonary infarction.

repeated components of a single process:

  • OP (organizing pneumonia).
  • Eosinophilic pneumonia, for example:
    • Simple pulmonary eosinophilia: may migrate over a period of days.
    • Chronic eosinophilic pneumonia: may migrate over a period of weeks to months.
  • Diffuse alveolar hemorrhage (with repeated episodes of bleeding).
  • Vasculitis:
    • EGPA (eosinophilic granulomatosis with polyangiitis).
    • GPA (granulomatosis with polyangiitis).
  • HP (hypersensitivity pneumonitis).
  • Rare causes:
    • PAP (pulmonary alveolar proteinosis).
    • Lymphomatoid granulomatosis.
    • Parasitic infections.
    • ABPA (allergic bronchopulmonary aspergillosis).(35294814, 34407978)

💡 Infectious consolidations usually take a relatively prolonged time to resolve. Therefore, consolidation which is rapidly migrating argues against an infectious process.


questions & discussion

(back to contents)


To keep this page small and fast, questions & discussion about this post can be found on another page here.

Guide to emoji hyperlinks 🔗

  • 🧮 = Link to online calculator.
  • 💊 = Link to Medscape monograph about a drug.
  • 💉 = Link to IBCC section about a drug.
  • 📖 = Link to IBCC section covering that topic.
  • 🌊 = Link to FOAMed site with related information.
  • 📄 = Link to open-access journal article.
  • 🎥 = Link to supplemental media.

References

  • 15671390 Heo JN, Choi YW, Jeon SC, Park CK. Pulmonary tuberculosis: another disease showing clusters of small nodules. AJR Am J Roentgenol. 2005 Feb;184(2):639-42. doi: 10.2214/ajr.184.2.01840639 [PubMed]
  • 23436867 Nemec SF, Bankier AA, Eisenberg RL. Upper lobe-predominant diseases of the lung. AJR Am J Roentgenol. 2013 Mar;200(3):W222-37. doi: 10.2214/AJR.12.8961 [PubMed]
  • 23521438 Nemec SF, Bankier AA, Eisenberg RL. Lower lobe-predominant diseases of the lung. AJR Am J Roentgenol. 2013 Apr;200(4):712-28. doi: 10.2214/AJR.12.9253 [PubMed]
  • 26981938 Saukkonen K, Sharma A, Mark EJ. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 8-2016. A 71-Year-Old Man with Recurrent Fevers, Hypoxemia, and Lung Infiltrates. N Engl J Med. 2016 Mar 17;374(11):1077-85. doi: 10.1056/NEJMcpc1505680 [PubMed]
  • 29286851 Chaddha U, Lee C. Subacute Respiratory Illness with Peripheral Pulmonary Opacities. Ann Am Thorac Soc. 2018 Jan;15(1):107-109. doi: 10.1513/AnnalsATS.201708-659CC [PubMed]
  • 31200868 Ko JP, Girvin F, Moore W, Naidich DP. Approach to Peribronchovascular Disease on CT. Semin Ultrasound CT MR. 2019 Jun;40(3):187-199. doi: 10.1053/j.sult.2018.12.002 [PubMed]
  • 36566029 Bhardwaj A, Ghosh S, Stoller JK. Radiographic Distribution as a Diagnostic Clue in Pulmonary Disease. Respir Care. 2023 Jan;68(1):151-166. doi: 10.4187/respcare.10210 [PubMed]

Books:

  • Shah, P. L., Herth, F. J., Lee, G., & Criner, G. J. (2018). Essentials of Clinical pulmonology. In CRC Press eBooks. https://doi.org/10.1201/9781315113807
  • Shepard, JO. (2019). Thoracic Imaging The Requisites (Requisites in Radiology) (3rd ed.). Elsevier.
  • Walker C & Chung JH (2019). Muller’s Imaging of the Chest: Expert Radiology Series. Elsevier.
  • Palange, P., & Rohde, G. (2019). ERS Handbook of Respiratory Medicine. European Respiratory Society.
  • Rosado-De-Christenson, M. L., Facr, M. L. R. M., & Martínez-Jiménez, S. (2021). Diagnostic imaging: chest. Elsevier.
  • Murray & Nadel: Broaddus, V. C., Ernst, J. D., MD, King, T. E., Jr, Lazarus, S. C., Sarmiento, K. F., Schnapp, L. M., Stapleton, R. D., & Gotway, M. B. (2021). Murray & Nadel’s Textbook of Respiratory Medicine, 2-Volume set. Elsevier.
  • Fishman's: Grippi, M., Antin-Ozerkis, D. E., Cruz, C. D. S., Kotloff, R., Kotton, C. N., & Pack, A. (2023). Fishman’s Pulmonary Diseases and Disorders, Sixth Edition (6th ed.). McGraw Hill / Medical.

The Internet Book of Critical Care is an online textbook written by Josh Farkas (@PulmCrit), an associate professor of Pulmonary and Critical Care Medicine at the University of Vermont.


Who We Are

We are the EMCrit Project, a team of independent medical bloggers and podcasters joined together by our common love of cutting-edge care, iconoclastic ramblings, and FOAM.

Resus Leadership Academy

Subscribe by Email

EMCrit®️ is the registered trademark of Metasin LLC. All EMCrit Content is a product of EMCrit LLC; Copyright 2009-. All PulmCrit and IBCC Content are a product of Farkas Medical LLC; Copyright 2009-. This site represents our opinions only. See our full disclaimer, privacy policy, commenting policy, terms of service, and credits and attribution.AI Use Prohibited: Content on this website may not be used in the training or development of AI systems without our express permission.